Geyer, P.E.* ; Hornburg, D.* ; Pernemalm, M.* ; Hauck, S.M. ; Palaniappan, K.K.* ; Albrecht, V.* ; Dagley, L.F.* ; Moritz, R.L.* ; Yu, X.* ; Edfors, F.* ; Vandenbrouck, Y.* ; Mueller-Reif, J.B.* ; Sun, Z.* ; Brun, V.* ; Ahadi, S.* ; Omenn, G.S.* ; Deutsch, E.W.* ; Schwenk, J.M.*
The circulating proteome─technological developments, current challenges, and future trends.
J. Proteome Res. 23, 5279-5295 (2024)
Recent improvements in proteomics technologies have fundamentally altered our capacities to characterize human biology. There is an ever-growing interest in using these novel methods for studying the circulating proteome, as blood offers an accessible window into human health. However, every methodological innovation and analytical progress calls for reassessing our existing approaches and routines to ensure that the new data will add value to the greater biomedical research community and avoid previous errors. As representatives of HUPO's Human Plasma Proteome Project (HPPP), we present our 2024 survey of the current progress in our community, including the latest build of the Human Plasma Proteome PeptideAtlas that now comprises 4608 proteins detected in 113 data sets. We then discuss the updates of established proteomics methods, emerging technologies, and investigations of proteoforms, protein networks, extracellualr vesicles, circulating antibodies and microsamples. Finally, we provide a prospective view of using the current and emerging proteomics tools in studies of circulating proteins.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Ptm ; Peptideatlas ; Affinity ; Biomarker Discovery ; Blood ; Extracellular Vesicle ; Mass Spectrometry ; Microsampling ; Plasma ; Serum; Human Plasma Proteome; Biomarker Discovery; Mass-spectrometry; Proteogenomic Characterization; Serum-proteins; Glycosylation; Genetics; Health; Assay; Associations
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
1535-3893
e-ISSN
1535-3907
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 23,
Heft: 12,
Seiten: 5279-5295
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Chemical Society (ACS)
Verlagsort
1155 16th St, Nw, Washington, Dc 20036 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-505700-001
A-630700-001
Förderungen
Knut and Alice Wallenberg Foundation
National Institutes of Health
German Ministry for Science and Education funding action CLINS-PECT-M
National Science Foundation
Max Planck Society
Copyright
Erfassungsdatum
2024-11-04